Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Age Is the Strongest Determinant of Leukemia Blast Cell Gene Expression in MLL -Rearranged Infant ALL and MLL-AF4 Directs a Distinct Gene Expression Profile Related to CNS Disease.

Blaine W. Robinson, PhD, Kajia Cao, PhD, Joanne M. Hilden, MD, Patricia A. Dinndorf, MD, Nyla A. Heerema, PhD, Harland N. Sather, Ron McGlennen, Stephen P. Hunger, MD, Gregory H. Reaman, MD, Li-San Wang, PhD, Carolyn A. Felix, MD

Blood (2008) 112 (11): 1200.

https://doi.org/10.1182/blood.V112.11.1200.1200

Published: 2008

Journal Articles

A PAI-1 ( SERPINE1 ) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

Deborah French, Leo H. Hamilton, Leonard A. Mattano, Jr, Harland N. Sather, Meenakshi Devidas, James B. Nachman, Mary V. Relling

Blood (2008) 111 (9): 4496–4499.

https://doi.org/10.1182/blood-2007-11-123885

Published: 2008

Journal Articles

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Nita L. Seibel, Peter G. Steinherz, Harland N. Sather, James B. Nachman, Cynthia DeLaat, Lawrence J. Ettinger, David R. Freyer, Leonard A. Mattano, Jr, Caroline A. Hastings, Charles M. Rubin, Kathy Bertolone, Janet L. Franklin, Nyla A. Heerema, Torrey L. Mitchell, Allan F. Pyesmany, Mei K. La, Cheryl Edens, Paul S. Gaynon

Blood (2008) 111 (5): 2548–2555.

https://doi.org/10.1182/blood-2007-02-070342

Published: 2008

Journal Articles

Outcomes for B-Precursor Patients in Legacy Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) Studies in Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.

Paul S. Gaynon, MD, Bruce C. Camitta, MD, Yousif Matloub, MD, Paul L. Martin, MD, Naomi Winick, MD, Nita L. Seibel, MD, W. Paul Bowman, MD, Harland N. Sather, PhD, Meenakshi Devidas, PhD, Stephen Hunger, MD, William L. Carroll, MD

Blood (2007) 110 (11): 847.

https://doi.org/10.1182/blood.V110.11.847.847

Published: 2007

Journal Articles

Outcomes in Children and Adolescents with a Markedly Elevated White Blood Cell Count (>200,000) at Diagnosis of High Risk Acute Lymphoblastic Leukemia (ALL): A Report from the Children’s Oncology Group.

Caroline Hastings, MD, Harland N. Sather, PhD, Nita L. Seibel, MD, James Nachman, MD, Peter G. Steinherz, MD, Kathy Bertolone, FNP, Cynthia DeLaat, MD, Lawrence J. Ettinger, MD, Janet Franklin, MD, David Robert Freyer, DO, Leonard A. Mattano, MD, Torrey L. Mitchell, MD, Charles M. Rubin, MD, Allan F. Pyesmany, MD, Nyla A. Heerema, PhD, Cheryl Edens, Paul S. Gaynon, MD

Blood (2006) 108 (11): 1870.

https://doi.org/10.1182/blood.V108.11.1870.1870

Published: 2006

Journal Articles

A SERPINE1 ( PAI-1 ) Single Nucleotide Polymorphism Predicts Osteonecrosis in Children Treated for Acute Lymphoblastic Leukemia: Results of the Children’s Oncology Group (COG) Study AALL03B2.

Leo H. Hamilton, MD, Leonard A. Mattano, MD, Harland N. Sather, PhD, Mary V. Relling, PharmD

Blood (2006) 108 (11): 709.

https://doi.org/10.1182/blood.V108.11.709.709

Published: 2006

Journal Articles

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

Kirk R. Schultz, D. Jeanette Pullen, Harland N. Sather, Jonathan J. Shuster, Meenakshi Devidas, Michael J. Borowitz, Andrew J. Carroll, Nyla A. Heerema, Jeffrey E. Rubnitz, Mignon L. Loh, Elizabeth A. Raetz, Naomi J. Winick, Stephen P. Hunger, William L. Carroll, Paul S. Gaynon, Bruce M. Camitta

Blood (2006) 109 (3): 926–935.

https://doi.org/10.1182/blood-2006-01-024729

Published: 2006

Journal Articles

Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study

James A. Whitlock, Harland N. Sather, Paul Gaynon, Leslie L. Robison, Robert J. Wells, Michael Trigg, Nyla A. Heerema, Smita Bhatia

Blood (2005) 106 (13): 4043–4049.

https://doi.org/10.1182/blood-2003-10-3446

Published: 2005

Journal Articles

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Naomi P. Moskowitz, MD, Deepa Bhojwani, MD, Huining Kang, PhD, Dong-Joon Min, PhD, Jeffrey Potter, PhD, Richard Harvey, PhD, Nita L. Seibel, MD, Elizabeth Raetz, MD, Harland N. Sather, PhD, Stephen P. Hunger, MD, Cheryl L. Willman, MD, William L. Carroll, MD

Blood (2005) 106 (11): 1449.

https://doi.org/10.1182/blood.V106.11.1449.1449

Published: 2005

Journal Articles

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Robert Cho, MD, Linda C. Stork, MD, Paul S. Gaynon, MD, Harland N. Sather, PhD, Mei K. La, MS, Raymond J. Hutchinson, MD

Blood (2005) 106 (11): 867.

https://doi.org/10.1182/blood.V106.11.867.867

Published: 2005

Journal Articles

Pharmacokinetics and Pharmacodynamics of Three Asparaginases in Pediatric Patients with Higher Risk Acute Lymphoblastic Leukemia: A Report from CCG-1961.

Eduard H. Panosyan, M.D., Nita L. Seibel, M.D., Rita S. Grigoryan, M.D., Ioannis A. Avramis, B.S., Jon D. Jaques, Lawrence J. Ettinger, M.D., Paul S. Gaynon, M.D., Harland N. Sather, Ph.D., Janet Franklin, M.D., Fu Cecilia, M.D., Stuart E. Siegel, M.D., Howard J. Fingert, M.D., Vassilios I. Avramis, Ph.D.

Blood (2004) 104 (11): 2745.

https://doi.org/10.1182/blood.V104.11.2745.2745

Published: 2004

Journal Articles

Treatment of High Risk T-Cell Acute Lymphoblastic Leukemia (T-ALL): Comparison of Recent Experience of the Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG).

Nita L. Seibel, M.D., Barbara L. Asselin, M.D., James B. Nachman, M.D., Peter Steinherz, M.D., Bruce Camitta, M.D., Meenakshi Devidas, Ph.D., Harland N. Sather, Ph.D.

Blood (2004) 104 (11): 681.

https://doi.org/10.1182/blood.V104.11.681.681

Published: 2004

Journal Articles

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Bruce C. Bostrom, Martha R. Sensel, Harland N. Sather, Paul S. Gaynon, Mei K. La, Katherine Johnston, Gary R. Erdmann, Stuart Gold, Nyla A. Heerema, Raymond J. Hutchinson, Arthur J. Provisor, Michael E. Trigg

Blood (2003) 101 (10): 3809–3817.

https://doi.org/10.1182/blood-2002-08-2454

Published: 2003

Journal Articles

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia

Smita Bhatia, Harland N. Sather, Nyla A. Heerema, Michael E. Trigg, Paul S. Gaynon, Leslie L. Robison

Blood (2002) 100 (6): 1957–1964.

https://doi.org/10.1182/blood-2002-02-0395

Published: 2002

Journal Articles

Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983

Smita Bhatia, Harland N. Sather, Olga B. Pabustan, Michael E. Trigg, Paul S. Gaynon, Leslie L. Robison

Blood (2002) 99 (12): 4257–4264.

https://doi.org/10.1182/blood.V99.12.4257

Published: 2002

Journal Articles

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Beverly J. Lange, Bruce C. Bostrom, Joel M. Cherlow, Martha G. Sensel, Mei K. L. La, Wayne Rackoff, Nyla A. Heerema, Robert S. Wimmer, Michael E. Trigg, Harland N. Sather

Blood (2002) 99 (3): 825–833.

https://doi.org/10.1182/blood.V99.3.825

Published: 2002

Journal Articles

Hemizygous p16 INK4A deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse

Tina L. Carter, Paul M. Watt, Rolee Kumar, Paul R. Burton, Gregory H. Reaman, Harland N. Sather, David L. Baker, Ursula R. Kees

Blood (2001) 97 (2): 572–574.

https://doi.org/10.1182/blood.V97.2.572

Published: 2001

Journal Articles

Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Nyla A. Heerema, James B. Nachman, Harland N. Sather, Martha G. Sensel, Mei K. Lee, Raymond Hutchinson, Beverly J. Lange, Peter G. Steinherz, Bruce Bostrom, Paul S. Gaynon, Fatih Uckun

Blood (1999) 94 (12): 4036–4045.

https://doi.org/10.1182/blood.V94.12.4036

Published: 1999

Journal Articles

Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Cancer Group

Nyla A. Heerema, Harland N. Sather, Martha G. Sensel, Wen Liu-Mares, Beverly J. Lange, Bruce C. Bostrom, James B. Nachman, Peter G. Steinherz, Raymond Hutchinson, Paul S. Gaynon, Diane C. Arthur, Fatih M. Uckun

Blood (1999) 94 (5): 1537–1544.

https://doi.org/10.1182/blood.V94.5.1537

Published: 1999

Journal Articles

Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children’s Cancer Group and Pediatric Oncology Branch Study

Frank M. Balis, John S. Holcenberg, David G. Poplack, Jeffrey Ge, Harland N. Sather, Robert F. Murphy, Matthew M. Ames, Mary J. Waskerwitz, David G. Tubergen, Solomon Zimm, Gerald S. Gilchrist, W. Archie Bleyer

Blood (1998) 92 (10): 3569–3577.

https://doi.org/10.1182/blood.V92.10.3569

Published: 1998

NARROW

Age Is the Strongest Determinant of Leukemia Blast Cell Gene Expression in MLL -Rearranged Infant ALL and MLL-AF4 Directs a Distinct Gene Expression Profile Related to CNS Disease.

A PAI-1 ( SERPINE1 ) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Outcomes for B-Precursor Patients in Legacy Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG) Studies in Childhood Acute Lymphoblastic Leukemia (ALL): A Children’s Oncology Group (COG) Report.

Outcomes in Children and Adolescents with a Markedly Elevated White Blood Cell Count (>200,000) at Diagnosis of High Risk Acute Lymphoblastic Leukemia (ALL): A Report from the Children’s Oncology Group.

A SERPINE1 ( PAI-1 ) Single Nucleotide Polymorphism Predicts Osteonecrosis in Children Treated for Acute Lymphoblastic Leukemia: Results of the Children’s Oncology Group (COG) Study AALL03B2.

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Pharmacokinetics and Pharmacodynamics of Three Asparaginases in Pediatric Patients with Higher Risk Acute Lymphoblastic Leukemia: A Report from CCG-1961.

Treatment of High Risk T-Cell Acute Lymphoblastic Leukemia (T-ALL): Comparison of Recent Experience of the Children’s Cancer Group (CCG) and Pediatric Oncology Group (POG).

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia

Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Hemizygous p16 INK4A deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse

Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Cancer Group

Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children’s Cancer Group and Pediatric Oncology Branch Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only